Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.96 M1.89 M1.96 M2.04 M2.02 M 7.91 M Research & development 1 00007 000-6 0000 1 000 Operating income -777 K-636 K-725 K-1.21 M-958 K -3.53 M Non-Operating Income, Total 99 K-4 00078 K286 K87 K 447 K Interest expense, net of interest capitalized ————11 K — Non-Operating Income, excl. Interest Expenses 99 K-4 00078 K286 K87 K 447 K Unusual income/expense 29 K4 00059 K118 K129 K 310 K Pretax income -678 K-640 K-647 K-928 K-871 K -3.09 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest 34 K25 K6 00042 K56 K 129 K After tax other income/expense ————— — Net income before discontinued operations -712 K-665 K-653 K-970 K-927 K -3.21 M Discontinued operations ————— — Net income -712 K-665 K-653 K-970 K-927 K -3.21 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -712 K-665 K-653 K-970 K-927 K -3.21 M Basic earnings per share (Basic EPS) -0.09-0.09-0.08-0.12-0.11 -0.4 Diluted earnings per share (Diluted EPS) -0.09-0.09-0.08-0.12-0.11 -0.4 Average basic shares outstanding 7.65 M7.65 M7.97 M7.85 M8.2 M — Diluted shares outstanding 7.65 M7.65 M7.97 M7.85 M8.2 M — EBITDA -663 K-525 K-612 K-1.1 M-859 K -3.1 M EBIT -777 K-636 K-725 K-1.21 M-958 K -3.53 M Cost of revenue 1.62 M1.63 M1.69 M1.98 M1.59 M 6.88 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 114 K111 K113 K112 K99 K 435 K